Longitudinal C-reactive protein (CRP) as an individualized dynamic predictor for metastatic cancer patients treated with immune checkpoint inhibitors: Findings from the prospective ST-ICI cohort.

Zhou JG, Ma H, Gaipl U, Frey B, Hecht M, Fietkau R (2021)

Publication Type: Conference contribution

Publication year: 2021

Journal

Cancer Research American Association for Cancer Research

Publisher: AMER ASSOC CANCER RESEARCH

City/Town: PHILADELPHIA

Conference Proceedings Title: CANCER RESEARCH

DOI: 10.1158/1538-7445.am2021-382

Authors with CRIS profile

Udo Gaipl Department of Radiation Oncology Benjamin Frey Department of Radiation Oncology Markus Hecht Department of Radiation Oncology Rainer Fietkau Lehrstuhl für Strahlentherapie

Involved external institutions

Zunyi Medical University CN China (CN)

How to cite

APA:

Zhou, J.-G., Ma, H., Gaipl, U., Frey, B., Hecht, M., & Fietkau, R. (2021). Longitudinal C-reactive protein (CRP) as an individualized dynamic predictor for metastatic cancer patients treated with immune checkpoint inhibitors: Findings from the prospective ST-ICI cohort. In CANCER RESEARCH. PHILADELPHIA: AMER ASSOC CANCER RESEARCH.

MLA:

Zhou, Jian-Guo, et al. "Longitudinal C-reactive protein (CRP) as an individualized dynamic predictor for metastatic cancer patients treated with immune checkpoint inhibitors: Findings from the prospective ST-ICI cohort." Proceedings of the CANCER RESEARCH PHILADELPHIA: AMER ASSOC CANCER RESEARCH, 2021.

BibTeX: Download